Headaches

Correction: Diagnosis challenges and accessibility barriers to migraine management in Southeast Asia: results from the South-East Asia Local breAch on MigraiNe Treatment (SEALANT) study

Diagnosis Challenges There are numerous obstacles in accurately diagnosing migraines within Southeast Asia, significantly impacting patient care. The complexities often

Correction: Diagnosis challenges and accessibility barriers to migraine management in Southeast Asia: results from the South-East Asia Local breAch on MigraiNe Treatment (SEALANT) study Read Post »

Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial

Study Overview The research presented focuses on evaluating the efficacy and safety of a fixed-dose combination of daily doravirine (100

Fixed-dose daily doravirine (100 mg) with islatravir (0·25 mg) versus bictegravir, emtricitabine, and tenofovir alafenamide for initial HIV-1 therapy: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial Read Post »

The human disharmony loop: high rates of return to work in intractable workers’ compensation patients undergoing surgical release of the pectoralis minor with infraclavicular neurolysis

Study Overview The research focuses on a cohort of patients intertwined with the complexities of workers’ compensation, particularly those regarded

The human disharmony loop: high rates of return to work in intractable workers’ compensation patients undergoing surgical release of the pectoralis minor with infraclavicular neurolysis Read Post »

Scroll to Top